Combined model (THIOREDOXIN and AFP) increased the sensitivity for HCC to 88.7%, with a specificity of 92.2%, and the AUROC was 0.98 (95% CI: 0.97– 0.99; Figure 2a). The gene discussed is AFP; the disease is hepatocellular carcinoma.